Tag: Hepatitis
Interferon-Free, Tailored Tx Beneficial in HCV-Associated MC
Guideline-tailored therapy highly effective, safe for hepatitis C virus-associated mixed cryoglobulinemia
Elbasvir-Grazoprevir Effective for HCV With Opioid-Agonist Tx
High rates of sustained virologic response at 12 wks, regardless of drug use at baseline or during tx
Recent Increases in Rate of Hep C Detection in Young Women
Increase in rate of HCV detection in women of childbearing age, HCV testing among infants
Shared Drug Snorting Straws May Transmit Hepatitis C Virus
Findings among HCV-infected women reporting noninjection drug use
FDA Approves Epclusa for Chronic Hepatitis C
Combination drug treats six major strains of hepatitis C virus infection
Hep C Core Antigen Assays Show High Sensitivity, Specificity
Certain HCV core antigen assays could replace confirmatory nucleic acid testing for diagnosis of HCV
Tenofovir Disoproxil Fumarate Can Cut HBV Transmission
Use of TDF in pregnancy is associated with a reduced rate of mother-to-child transmission
Survival for HCV Cirrhosis, SVR Same As General Population
Findings in patients with compensated HCV cirrhosis who achieve SVR on interferon-based regimen
CDC: Hepatitis C Leads Infectious Disease Mortality in U.S.
CDC notes that nearly 20,000 Americans died in 2014 from hepatitis C infection
Adding Antiviral to Sorafenib Is Cost-Effective in HCC
More cost-effective than sorafenib monotherapy for HBV-related cancer
